LipoScience Receives 2012 Diagnostic Marketing Association Creative Communications First Place Award
NMR LipoProfile® test campaign communicates importance of LDL-particles in cardiovascular disease risk and management
RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical diagnostic tests using nuclear magnetic resonance (NMR) technology, today announced that it has received first place recognition at the 2012 Diagnostic Marketing Association (DxMA) Creative Communications Awards for the integrated print and online category for LipoScience’s NMR LipoProfile® test campaign.
The award was presented at the 2012 DxMA awards reception on April 25 in Chicago. The DxMA recognizes excellence in diagnostics marketing, advertising and promotional programming. LipoScience partnered with Motivation Mechanics, a Philadelphia-based marketing research and communications strategy firm, on the campaign.
“It is an honor to be recognized by the DxMA for our clinical communication initiatives,” said Mark Kirtland, Vice President, Marketing and Business Development at LipoScience. “The goal of our educational campaign continues to focus on increasing awareness of the NMR LipoProfile test and communicating the clinical value it can provide physicians and their patients in managing cardiovascular disease risk.”
“We are extremely proud of this industry award, which acknowledges the efforts of our marketing team to educate the broader physician community,” said Richard O. Brajer, President and Chief Executive Officer of LipoScience.
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.